Jan. 24, 2019
announced its 2018 annual report, which reveals annual income of Yuan4.025 billion which is 30.54% up and net profit attributable to shareholders of Yuan584 million which is 45.19% up year on year.
During the report period, the market demand for the main products of the company was quite desirable. Meanwhile the company actively organized production activities to ensure secured supplies to the market. Therefore, the sales of the main products increased greatly. Furthermore, the major subsidiaries of the company performed quite well. These achievements led to the company’s gross revenue, business profit and net profit attributable to shareholders to increase respectively by 30.54%, 47.57% and 45.19% year on year.
Lier Chemical has currently annual production capacity of 8,400 tons of glufosinate, 1,800 tons of clopyralid and 3,000 tons of picloram. In October 2018, the 1,000-ton flumioxazin production facility of its wholly-owned subsidiary Guang’an Lier Chemicals was brought on stream, which is expected to further increase the profitability of the company.